| e4cde2aa-9196-45b9-bedf-4679bd67e4ca | 14825997-7bb0-4b7a-a138-07f0443392b3 | 0092275 | HORMONIOTERAPIA DO CARCINOMA DE MAMA EM ESTÁDIO III (PRÉVIA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 54683962-9bf1-4173-9ded-46010801099e | 1d81e79b-564a-42e8-a1fb-70bcaab51ced | 0092276 | QUIMIOTERAPIA DE ADENOCARCINOMA DE CÓLON | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| bd3e83de-3ba9-40a5-94e2-b3c87e48b3df | a9fd69d6-78d0-4a01-bcd7-9f2674b80324 | 0092277 | QUIMIOTERAPIA DO ADENOCARCINOMA DE COLON AVANÇADO -1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 85e28bf8-a4e1-4dbc-9f66-dcbd1004d83c | 9560f700-952d-40bf-9ebe-7cad324c8115 | 0092278 | QUIMIOTERAPIA DO ADENOCARCINOMA DE COLON AVANÇADO - 2ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| f3159262-7614-490b-9b0b-1f9dcddc8500 | 8b4ac14a-819e-4a16-9494-fb0f76736709 | 0092279 | HORMONIOTERAPIA DO ADENOCARCINOMA DE ENDOMÉTRIO AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 1fb1fe90-5a8f-44f7-bdb3-ca5a5de35ac4 | 90068000-f641-4cdb-bc16-cce044eb990f | 0092280 | QUIMIOTERAPIA DO ADENOCARCINOMA DE ESTÔMAGO AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 302d540c-a755-462e-9020-17710485e7c3 | 25b77e8e-d4c0-4ca3-8909-802be846fc65 | 0092281 | QUIMIOTERAPIA DO ADENOCARCINOMA DE PÂNCREAS AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 6968b956-7fc7-4e62-b8fa-0af5fd3a0bdf | 4faec4c8-e525-460e-b480-7fb5c54ebe06 | 0092282 | QUIMIOTERAPIA DO ADENOCARCINOMA DE PRÓSTATA RESISTENTE A HORMONIOTERAPIA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| cacfa0bb-9ad5-4bbf-8dd6-987ffaf62d22 | 708b467e-b892-41bd-98d4-5de89c8d3a7e | 0092283 | QUIMIOTERAPIA DO CARCINOMA DE RETO AVANÇADO -1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 86b14c82-f28e-48f4-8881-9d4ff9f3003c | 19e5de84-a363-4bac-a4a6-3a0c7a4b8ad2 | 0092284 | QUIMIOTERAPIA DO CARCINOMA DE RETO AVANÇADO - 2ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| e22ce914-be0e-4b3e-845a-98fe591621c9 | 17769baa-c04d-4291-9e3a-2a03d3c4081a | 0092285 | QUIMIOTERAPIA DO APUDOMA/TUMOR NEUROENDÓCRINO AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| ca65758a-67b8-460b-9d42-e4d00fbb2b39 | b692ce4c-8f21-4930-98b0-ab8fe77f2261 | 0092286 | QUIMIOTERAPIA DO CARCINOMA DE ADRENAL AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 3f43b807-2a96-4570-96d9-0fe49dc41ea9 | 020ebd41-ada4-4ddc-a519-05681f764a43 | 0092287 | QUIMIOTERAPIA DO CARCINOMA DE NASOFARINGE AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 03bc9e6c-cc36-4d02-adfc-01602f12d034 | 4adea96d-3ffc-4d2f-a7ab-60d38860968e | 0092288 | QUIMIOTERAPIA DO CARCINOMA DE RIM AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 65b2a5ae-4136-428e-961c-8f324f510b90 | c6c9e477-4387-44c4-8ce3-bbea593cee30 | 0092289 | QUIMIOTERAPIA DO CARCINOMA EPIDERMÓIDE / ADENOCARCINOMA DE ESÔFAGO AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 73c28d5f-e3fb-4236-80b0-837fee2b7423 | 1af94c2e-1b96-41c1-a3be-12ad83275e0f | 0092290 | QUIMIOTERAPIA DO CARCINOMA EPIDERMÓIDE / ADENOCARCINOMA DO COLO OU DO CORPO UTERINO AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b6b8a2cc-a29f-417b-8095-d64ffada0597 | 0507ce05-5918-4a25-b1e9-6d4d1aa4b72f | 0092291 | QUIMIOTERAPIA DO CARCINOMA EPIDERMÓIDE DE RETO/ CANAL ANAL/ MARGEM ANAL AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| d925fb0b-d887-43a2-b062-252839a8614f | 88f44294-1ecd-4455-9a3e-37c8f0ba3e0b | 0092292 | QUIMIOTERAPIA DO CARCINOMA EPIDERMÓIDE DE CABEÇA E PESCOÇO AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 858af7e4-8ba1-4d14-bbdf-0ad3c7f3d7e1 | 68a07bf2-1d01-4909-b16a-5518183273c2 | 0092293 | QUIMIOTERAPIA DO CARCINOMA PULMONAR DE CÉLULAS NÃO PEQUENAS AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 9d1438c6-3d8e-4e86-9812-3990531e641c | c6a5bc9a-852f-43da-8447-adf149e1fe6e | 0092294 | QUIMIOTERAPIA DO CARCINOMA PULMONAR INDIFERENCIADO DE CÉLULAS PEQUENAS AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 78974a36-806b-4b60-9b90-84a542d0565b | dc07324d-5227-4192-bb0a-624cc2c655b7 | 0092295 | QUIMIOTERAPIA DO MELANOMA MALIGNO AVANÇADO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| f49e9e58-bd5e-492a-a91d-afdd8e083c87 | 5b821531-8936-4ae4-b8de-8829cca90e60 | 0092296 | QUIMIOTERAPIA DE METÁSTASE DE ADENOCARCINOMA DE ORIGEM DESCONHECIDA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| e28abd4b-278f-41dc-a7bc-893c81331721 | 8cf3a246-92b6-4396-8a9c-1522cd21e903 | 0092297 | QUIMIOTERAPIA DE METÁSTASE DE CARCINOMA EPIDERMÓIDE/CARCINOMA NEUROENDOCRINO DE ORIGEM DESCONHECIDA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 25f80b47-c4d1-4964-a992-899cf96eaecc | 87b3f9d8-c176-400d-90b6-7a235f8a50a9 | 0092298 | QUIMIOTERAPIA DE METÁSTASE DE NEOPLASIA MALIGNA INDIFERENCIADA DE ORIGEM DESCONHECIDA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| cd236a0b-ec68-49db-aa3f-7cb9408a45b7 | e12cbbd8-0e33-47ee-9b29-4de6d73ea650 | 0092299 | QUIMIOTERAPIA DO MELANOMA MALIGNO (ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| a7ad1813-e0d0-4cb0-8f93-19a8164e875d | e12cbbd8-0e33-47ee-9b29-4de6d73ea650 | 0092300 | QUIMIOTERAPIA DE LINFOMA FOLICULAR- 2 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| a758ef94-0c14-41f5-8878-fc45944c838c | 0df8411a-a77b-4029-a9ad-c257a3a05f31 | 0092301 | QUIMIOTERAPIA COM DUPLO ANTI-HER-2 DO CARCINOMA DE MAMA HER-2 POSITIVO ? 1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| f5696a76-03c0-45bb-b956-7d67a7f4d3c1 | 694c52b7-5b4c-4061-a1ae-17b1bcaf08ed | 0092302 | QUIMIOTERAPIA DO CARCINOMA DE MAMA COM DUPLO ANT HER-2 POSITIVO 1º LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 0d8a1f94-1bcf-40d6-ab2f-91c3e787e821 | 6aff980e-7a24-44a5-84ad-2f997fe085c5 | 0092303 | POLIQUIMOTERAPIA DO CARCONOMA DE MAMA COM DUPLO ANT HER - 2 POSITIVO 1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| cd836a93-dd9d-4781-8928-7bcc2aedb606 | 13f9f44f-68e5-4b97-928f-a697d2410563 | 0092304 | QUIMIOTERAPIA DE MIELOMA MÚLTIPLO ? 1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| c0563453-45c5-4b47-9942-c7bcabd56bfb | <span class="null">NULL</span> | 0092305 | QUIMIOTERAPIA DE MIELOMA MÚLTIPLO ? 2ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| bdfa71ca-88d9-4864-980a-4d6b8c4bb855 | fa5e12bf-4231-4a10-98b1-7d2c453a7e6f | 0092306 | QUIMIOTERAPIA DE LINFOMA NÃO HODGKIN GRAU INTERMEDIÁRIO OU ALTO - 2ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 9e3e3cd8-c536-4d06-8408-52b7d94990de | 90068000-f641-4cdb-bc16-cce044eb990f | 0093001 | ADENOCARCINOMA DE PROSTATA - HORMONIOTERAPIA - 1A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| dbbaf440-2e33-4c1d-a829-bf63b19f0c19 | 25b77e8e-d4c0-4ca3-8909-802be846fc65 | 0093002 | ADENOCARCINOMA DE PROSTATA - HORMONIOTERAPIA - 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 453c4a60-5279-4c32-a83e-c5638db187db | 4faec4c8-e525-460e-b480-7fb5c54ebe06 | 0093003 | ADENOCARCINOMA DE PROSTATA RESISTENTE A HORMONIOTERAPIA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 0a3354e7-da11-42a6-a9fd-d39406415570 | 1d81e79b-564a-42e8-a1fb-70bcaab51ced | 0093004 | ADENOCARCINOMA DE RETO 1A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 0c99aa76-ef2e-4bae-96a1-110b29190f8e | 14825997-7bb0-4b7a-a138-07f0443392b3 | 0093005 | ADENOCARCINOMA DE RETO 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| d2e5210a-4afb-42db-807b-72eccf70e2ff | 206a417b-d380-4e70-8531-ea017cc7b52c | 0093006 | ADENOCARCINOMA DE COLON 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| e6a5077c-be6e-4db7-969f-85c507202f26 | a9fd69d6-78d0-4a01-bcd7-9f2674b80324 | 0093007 | ADENOCARCINOMA DE COLON - 1A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 7137bc16-92cc-4fa5-bfc8-852c12d241bf | 9560f700-952d-40bf-9ebe-7cad324c8115 | 0093008 | ADENOCARCINOMA DE COLON (ESTADIOS II E III OU DUKES B E C) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 0ec27d5e-969b-44c0-a894-b68c930baa48 | 8b4ac14a-819e-4a16-9494-fb0f76736709 | 0093009 | ADENOCARCINOMA DE ENDOMETRIO - HORMONIOTERAPIA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 13385b48-f0b6-4d1e-b047-edec587f0192 | 8dbffd3c-86cf-46fa-bb0e-6408ad12664b | 0093010 | ADENOCARCINOMA DE ESTOMAGO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 59133681-ca06-4400-b065-9ac7a1bc261a | 8df398c4-9cc9-4db0-9697-318348366052 | 0093011 | ADENOCARCINOMA DE PANCREAS | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| e4b6b139-0475-41bf-8228-c2f1280081d4 | 708b467e-b892-41bd-98d4-5de89c8d3a7e | 0093012 | ADENOCARCINOMA DE RETO (ESTADIOS II E III OU DUKES B E C) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 2f41cce3-12ba-4440-ba44-3ccc7c509998 | <span class="null">NULL</span> | 0093013 | AMNIOCENTESE | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 22309708-ac5d-43c0-9d25-e6e35db4dd44 | <span class="null">NULL</span> | 0093014 | APUDOMA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 214b1b80-6cb5-4bb5-988d-21f648df4dd9 | <span class="null">NULL</span> | 0093015 | BETATERAPIA DERMICA (POR CAMPO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| f0f647da-6411-4586-8b49-3621e3b0116a | <span class="null">NULL</span> | 0093016 | BETATERAPIA OFTALMICA ( POR CAMPO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 6cd20174-6e3a-4afe-bfe8-ee641366e180 | <span class="null">NULL</span> | 0093017 | BETATERAPIA PARA PROFILAXIA DE PTERÍGIO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 34b559e5-7d9a-48d6-93eb-43b785c0a9f0 | <span class="null">NULL</span> | 0093018 | BRAQUITERAPIA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |